Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 13.45% is 162% above its 5-year average of 5.12%, near the high end of its 5-year range (-4.29%–13.45%).
As of the fiscal period ended Tuesday, June 30, 2026. 24.28% above its 12-month average of 10.82%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 13.45%.
RETURN ON INVESTED CAPITAL (ROIC)
13.45%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
10.82%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
7.52%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
5.12%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+24.28%
CURRENT VS 3Y AVG
+78.70%
CURRENT VS 5Y AVG
+162.50%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 837 covered companies
CURRENT VS SECTOR MEDIAN
+137.70%
vs the sector median at left
Amneal Pharmaceuticals, Inc.
Market Cap
$6.48B
Return on Invested Capital (ROIC)
13.45%
TTM Avg
10.82%
3Y Avg
7.52%
5Y Avg
5.12%
Market Cap
$6.51B
Return on Invested Capital (ROIC)
11.03%
TTM Avg
15.62%
3Y Avg
13.60%
5Y Avg
7.69%
Market Cap
$6.57B
Return on Invested Capital (ROIC)
-4.30%
TTM Avg
9.38%
3Y Avg
-2.79%
5Y Avg
-9.92%
Market Cap
$6.63B
Return on Invested Capital (ROIC)
-76.00%
TTM Avg
-62.20%
3Y Avg
-56.39%
5Y Avg
-47.69%
Market Cap
$6.66B
Return on Invested Capital (ROIC)
19.48%
TTM Avg
18.99%
3Y Avg
19.98%
5Y Avg
22.15%
Market Cap
$6.23B
Return on Invested Capital (ROIC)
-63.96%
TTM Avg
-73.62%
3Y Avg
-66.48%
5Y Avg
-67.69%
Market Cap
$6.99B
Return on Invested Capital (ROIC)
2.12%
TTM Avg
16.37%
3Y Avg
14.48%
5Y Avg
9.33%
Market Cap
$5.95B
Return on Invested Capital (ROIC)
3.91%
TTM Avg
0.53%
3Y Avg
0.65%
5Y Avg
2.31%
Market Cap
$5.89B
Return on Invested Capital (ROIC)
-20.26%
TTM Avg
-47.02%
3Y Avg
-56.93%
5Y Avg
-48.62%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.48B | 13.45% | 10.82% | 7.52% | 5.12% |
| Lantheus Holdings, Inc. (LNTH)vs › | $6.51B | 11.03% | 15.62% | 13.60% | 7.69% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.57B | -4.30% | 9.38% | -2.79% | -9.92% |
| Immunovant, Inc. (IMVT)vs › | $6.63B | -76.00% | -62.20% | -56.39% | -47.69% |
| Chemed Corporation (CHE)vs › | $6.66B | 19.48% | 18.99% | 19.98% | 22.15% |
| Rhythm Pharmaceuticals, Inc. (RYTM)vs › | $6.23B | -63.96% | -73.62% | -66.48% | -67.69% |
| Alkermes plc (ALKS)vs › | $6.99B | 2.12% | 16.37% | 14.48% | 9.33% |
| Ligand Pharmaceuticals Incorporated (LGND)vs › | $5.95B | 3.91% | 0.53% | 0.65% | 2.31% |
| GRAIL Inc. (GRAL)vs › | $5.89B | -20.26% | -47.02% | -56.93% | -48.62% |
| Kiniksa Pharmaceuticals International, plc (KNSA)vs › | $5.87B | 9.76% | -0.67% | -1.10% | -22.88% |
ROIC
13.4%
ROE
476.5%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | 13.45% |
| 2026-03-31 | 13.04% |
| 2025-12-31 | 10.63% |
| 2025-09-30 | 8.79% |
| 2025-06-30 | 8.19% |
| 2025-03-31 | 7.72% |
| 2024-12-31 | 9.25% |
| 2024-09-30 | 6.88% |
| 2024-06-30 | 6.17% |
| 2024-03-31 | 5.62% |
| 2023-12-31 | 7.20% |
| 2023-09-30 | 7.46% |
| 2023-06-30 | 4.87% |
| 2023-03-31 | -2.74% |
| 2022-12-31 | -3.03% |
| 2022-09-30 | -3.81% |
| 2022-06-30 | -4.29% |
| 2022-03-31 | 2.16% |
| 2021-12-31 | 2.98% |
| 2021-09-30 | 3.86% |
| 2021-06-30 | 3.18% |
| 2021-03-31 | 2.36% |
| 2020-12-31 | 2.70% |
| 2020-09-30 | 1.41% |
| 2020-06-30 | -1.95% |
| 2020-03-31 | -2.57% |
| 2019-12-31 | -7.93% |
| 2019-09-30 | -6.34% |
| 2019-06-30 | -0.41% |
| 2019-03-31 | -4.67% |
| 2018-12-31 | -0.51% |
| 2018-09-30 | 0.89% |
| 2018-06-30 | 1.01% |
| 2018-03-31 | 25.24% |
| 2017-12-31 | 21.36% |
| 2017-09-30 | 24.18% |
